Report: Cook stent meets safety, effectiveness goals

Zilver PTX, a drug-coated stent from Cook Medical, met safety and effectiveness goals for treating blocked femoral arteries, FDA staff said. Their findings came in a report issued ahead of an Oct. 13 meeting of outside experts who will weigh in on whether to clear the device. The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg. News

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.